Brain Matters (Audio)

Latest Episodes:

Karen Gaffney: We Need Medical Research that Improves Our Lives Apr 13, 2018

Show notes

Karen Gaffney, advocate and disability champion, discusses her life with Down syndrome. She also talks about the impact that pre natal testing is having on the Down syndrome community and advocates for medical research to focus on the immediate needs such as Alzheimer's disease prevention. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33602]

Neurological Issues in Down Syndrome and Aging Apr 13, 2018

Show notes

Michael Rafii, MD, PhD describes the conditions that affect people with Down syndrome including vision issues, hearing issues, hormonal issue, spinal cord issues, sleep apnea, and Alzheimer's disease. He stresses the need for routine medical follow ups with primary care physicians and specialty clinics to make sure all changes in health are addressed. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33603]

Models Of / Models For Integrative and Whole Systems Research -- Part 2 Dec 22, 2017

Show notes

Can (Martin) Zhang of Harvard Medical School leads off the panel with a detailed discussion of factors leading to Alzheimer’s disease and the potential benefits of curcumin in treatment. He is followed by Rinchen Dhondrup of Qinghai University, who presents on treating chronic atrophic gastritis and Chenchen Wang of Tufts University who explains her work using Tibetan medicines and Tai Chi to treat rheumatoid arthritis, fibromyalgia and other chronic diseases as part of the Tibetan Medicine Conference on Mind-Body Health held at Harvard in October, 2017. Series: "Wellbeing " [Health and Medicine] [Show ID: 33048]

The Potential for Natural Products in Treating Alzheimer's Disease and Other Keynotes from 2017 Tibetan Medicine Conference on Mind-Body Health Dec 08, 2017

Show notes

Keynote talks at the 2017 Tibetan Medicine Conference on Mind-Body Health are presented here, including Rudolph Tanzi, PhD, of the Harvard Medical School who describes his research with natural products to prevent and treat Alzheimer's; Yumba of Lhasa on the Great Treasury of Tibetan Medical and Astronomical Texts; and Janet Gyatso of the Harvard Divinity School on the Challenges for the Study of Tibetan Medicine. Series: "Wellbeing " [Health and Medicine] [Show ID: 33044]

Designer DNA Drugs with Don Cleveland - On Our Mind Nov 01, 2017

Show notes

Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32505]

The Intersection of Behavior and Mental Health Through the Lens of Inflammation HIV Alzheimer's Disease and More with Igor Grant - On Our Mind May 09, 2017

Show notes

Igor Grant, MD, FRCP(C) pursues research that addresses real world behavioral problems. Studying the intersection of drugs of abuse (primarily methamphetamine) and infection, his work sheds light on the basic mechanisms of injury for people with HIV. He examines inflammation in the context of neurological disorders and measures the impact of chronic stress on Alzheimer's disease caregivers. Dr. Grant joins William Mobley, MD, PhD to discuss his life in science and his fascinating work. Series: "Brain Channel" [Health and Medicine] [Show ID: 32221]

Making an Old Brain Young? From Developmental Critical Periods to Alzheimer's Disease Apr 24, 2017

Show notes

2016 Kavli Prize recipient Carla Shatz from Stanford University presents a lively exploration of how understanding early stages of neural development may be leading to a pathway for developing treatments for Alzheimer's Disease. Series: "Alzheimer’s Disease" [Health and Medicine] [Science] [Show ID: 31763]

The Quest for Treatments for Alzheimer's Disease with Eric Siemers - On Our Mind Apr 10, 2017

Show notes

Eric Siemers, MD, Distinguished Medical Fellow at Eli Lilly and Company joins William Mobley, MD, PhD to discuss clinical trails for Alzheimer's disease. He explains the trial design, results, and future implications of the EXPEDITION3 trial for people with with mild dementia due to Alzheimer's disease. Learn more about potential treatments in the clinical trials pipeline that may impact both the symptoms and pathologies of Alzheimer's disease. Series: "Alzheimer’s Disease" [Health and Medicine] [Science] [Show ID: 31802]

The Oncoming Epidemic of Alzheimer's Disease with Maria Carrillo - On Our Mind Feb 23, 2017

Show notes

As baby boomers age, an unprecedented number of people will be diagnosed with Alzheimer's disease. The economic and social impacts will be wide reaching from cost of treatment to the effect on caregivers. Maria Carrillo, PhD, Chief Science Officer, Alzheimer’s Association joins Willliam Mobley. MD, PhD to discuss what can be done and how government, industry and the Alzheimer's Association are working together on larger scale trials and innovative projects. Series: "Alzheimer’s Disease" [Health and Medicine] [Show ID: 31801]

Research Ethics and Advancing the Future of Alzheimer's Disease Research with Ara Khachaturian - On Our Mind Jan 19, 2017

Show notes

Ara Khachaturian, PhD, chair and president of the National Biomedical Research Ethics Council joins WIilliam Mobley, MD, PhD to discuss the evolution of biomedical research in Alzheimer's disease and the ethical standards needed to maintain excellent patient care. From institutional review boards (IRB) to industry and academic partnerships, learn how we can support and maintain effective research infrastructure. Series: "Alzheimer’s Disease" [Health and Medicine] [Show ID: 31770]

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected